From Forest to Factory analyzes global supply chains for 2 critical vaccine adjuvants, QS-21 and MPL — used in vaccines for malaria, shingles, RSV, & a leading tuberculosis vaccine candidate. Read the full report here: www.treatmentactiongroup.org/publication/...

Yesterday, 175 governments pledged to accelerate responses to NCDs & mental health. Now they must take concrete actions to ensure everyone has affordable access to the medical tools they need. msfaccess.org/governments-...

Do you know how #algorithms can help diagnose the world's deadliest infectious disease? Find out in our latest newsletter 👇 msfaccess.org/newsletter/a...

Along with 10 other civil society organisations, we sent an open letter to the European Parliament’s Committee on Public Health, sharing recommendations to ensure that the Critical Medicines Act advances equitable access for all. msfaccess.org/cso-open-let...

Yesterday, at Abrascão, Brazil's largest public health congress, MSF Access' Marcela Vieira explored how patent monopolies raise prices, limit access to health products, and deepen health inequities... and she shared a way to challenge them: www.patentoppositions.org

Novo Nordisk discontinues key insulin products in EU/EEA for commercial reasons: “Yet another unacceptable example of pharmaceutical corporations putting profits before people’s health.” msfaccess.org/msf-responds...

Negotiations on the Pathogen Access and Benefit Sharing (PABS) system, a key aspect of the WHO Pandemic Agreement adopted in May this year, began today. Read our statement and asks: msfaccess.org/msf-welcomes...

Happening tomorrow!

On World Children’s Day (20 Nov 2025), TB activists and MSF marched in solidarity with children affected by tuberculosis at the Union World Conference on Lung Health in Copenhagen. To learn more about MSF’s work and engagement on TB in children, visit: www.msf.org/tactic-tuber...

On #WorldAMRAwarenessWeek, we’re calling for concrete action to ensure access to existing diagnostic tools, microbiology capacities, legacy & new lifesaving antibiotics, and care for all... + an increase in R&D for low-resource & humanitarian settings, where it's most needed.

🦠 By 2050, AMR is estimated to contribute to 8.2 million deaths worldwide. For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe. #WorldAMRAwarenessWeek

AMR, FTAs, TB, do you know what these acronyms mean, and what they have to do with access to health products? If you're curious, read our latest newsletter, and sign up for more access content! msfaccess.org/newsletter/a...

This World AMR Awareness Week, join a discussion on antimicrobial resistance in conflict-affected settings, where AMR's impact is severe due to limited access to infection prevention, diagnostics, and antimicrobials. 📅 Thur 20 Nov 🕐 13:30 – 15:00 CET fao.zoom.us/webinar/regi...

Today at @theunion.org we unveiled data from our operational research: ⚙️ @who.int recommended algorithms, for diagnosing tuberculosis in children can nearly double the number of children who can be initiated on lifesaving treatment. 🎉 msfaccess.org/msf-findings...

Today is World Diabetes Day. More than 800 million people have diabetes, most of whom live in low- and middle-income countries. For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.

Scientists discovered insulin over 100 years ago, envisioning a world where everyone could access #diabetes treatment. But it is often unavailable or unaffordable. Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.

It's starting soon! www.youtube.com/watch?v=XBqQ...

Today @who.int released their 2025 #tuberculosis report, and figures remain unacceptable: 1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap! msfaccess.org/msf-responds...

Half of children and young adolescents with tuberculosis are not diagnosed and therefore do not receive lifesaving treatment… but why? Take a look at the causes of this deadly gap, which we’ll be discussing in next week’s panel discussion. youtu.be/6k6YCqPUi_Y

Every child withTB deserves a healthy childhood. Yet in 2023, 1.25M fell ill with TB and nearly half were never diagnosed, thus never treated. Join our webinar moderated by @johngreensbluesky.bsky.social where survivors and treatment providers will discuss how to close these deadly gaps.

🦠 It's estimated that by 2050, antibiotic resistance will cause 8.22 million deaths per year. To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses. Learn more:

➡️ @saludporderecho.bsky.social reports that in Spain the public price of WHO recommended six-month treatment BPaLM regimen is priced at €58,000. In contrast, LMICs can access the same regimen for less than €250. saludporderecho.org/en/monopolie...

💊Patents, trade policy, and why people's access to the medicines they need is at stake.   MSF's Roshan John Joseph on India’s Free Trade Agreements with high-income countries, how they could mean higher medicine prices around the world, and why transparency in their negotiation matters.

MSF first witnessed the systemic gaps in access to WHO-recommended #tuberculosis treatments in 2022 when we launched a response in Poland to assist Ukrainian refugees and other migrants in accessing tuberculosis treatment. A TB survivor shared her experience 🧵

At a panel discussion yesterday in Brussels, we urged policymakers, parliamentarians, regulatory agencies, and procurement bodies in the EU and the EEA to take urgent steps to bridge the gap in accessing tuberculosis treatment in the region. msfaccess.org/msf-urges-eu...

⏰ Tomorrow! Don’t miss our panel on improving access to TB medicines in EU/EEA. People with TB still face barriers to effective treatment & prevention, let's discuss solutions. Register Now👉 us06web.zoom.us/webinar/regi...

People with TB in EU and EEA still face limited access to effective treatment and prevention medicines. How can we fix that? On 14 Oct, join our panel discussion on how to improve the availability and affordability of TB medicines in the region. Register us06web.zoom.us/webinar/regi...

Ahead of the WHO Eastern Mediterranean Regional Committee, MSF shared challenges in addressing antimicrobial resistance in fragile & conflict settings, where it's critical to measure access gaps & improve availability of diagnostics & antibiotics. www.emro.who.int/media/news/i...

While most countries agreed to the UN HLM Declaration on prevention & control of NCDs & mental health, it was not adopted. We urge countries to adopt the Declaration as it stands at the earliest opportunity & act to ensure equitable & affordable access to medical tools for all.

We welcome the agreement to provide ground-breaking HIV prevention drug at $40 in 2027, but global plans need to prioritise key populations and include the low- and middle-income countries to ensure sustainable access for all who need it. msfaccess.org/msf-supports...

⏰ Tomorrow, governments will gather at the United Nations High Level Meeting (UN HLM) in New York to agree to a political declaration that will guide them on how to prevent and control noncommunicable diseases (NCDs) – including diabetes – and mental health until 2030. 🧵

What happens when people face challenges accessing the diabetes care they need? Hear from Lecritia, Sana, and Ghassan, whose lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred. msfaccess.org/what-it-mean...

Scientists who discovered #insulin over 100 years ago envisioned a world where everyone could access diabetes treatment. And yet, diabetes treatment is too often unavailable or unaffordable. Learn more ⬇️ youtube.com/watch?v=v6R17w1pD0A&feature=youtu.be

Fleeing home while managing #diabetes can mean losing reliable access to insulin which, in turn, risks severe health consequences, even death. Ghassan undertook a long, difficult journey with a limited supply of insulin. How did he manage his treatment? 🧵

Managing #diabetes while living through a conflict can be challenging, especially when access to medical tools is disrupted. After the war broke out in Lebanon in 2024, Sana (14) had to change the way she monitored her blood glucose levels. 🧵 youtu.be/eg0BAJKtTXI

Even with access to the best tools, technology, and treatment, managing diabetes is complicated. What happens when people face challenges accessing the diabetes care they need due to corporate decisions, displacement, or conflict? 🧵

In 2024, only 16% of children in the Central African Republic had completed their full vaccination schedule, while 34% had never received any vaccine. In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.

In 2024, only 16% of children in the Central African Republic had completed their full vaccination schedule, while 34% had never received any vaccine. In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.

“I came to all three rounds, I know these vaccines protect my children.” - Cynthia, a mother of five, brought her youngest child to be vaccinated. MSF works with the Ministry of Health in the Central African Republic to carry out vaccination campaigns. msfaccess.org/motorbikes-c...

Today marks a critical milestone on the path towards increasing access to #diabetes treatment: ✔️ Rapid-acting insulin analogues and GLP-1 agonists have been added to the @who Model List of Essential Medicines (EML).

Reminder: Last date to register for this hybrid event focusing on #diagnostics challenges and solutions in Africa happening tomorrow.

Join us for a hybrid event at Tokyo International Conference on African Development #TICAD9 where we will discuss challenges & solutions for accessing diagnostics in Africa, feature MSF field innovations and explore collaborations with Japan. Register at www.msf.or.jp/event/detail...

Lenacapavir has been recommended by @who.int for HIV prevention this week. While this prevention medicine could be a game-changer in turning the tide on HIV epidemic, Gilead's licensing agreement will undermine broad access. Here's why 👇

The child immunisation data released this week by @unicef.org & @who.int shows that, yet again, the world is behind on its global immunisation targets.

MSF welcomes @who.int’s new guidelines for lenacapavir, a game-changing #HIV prevention drug. But we’re deeply concerned about restricted access due to Gilead’s licensing limitation.

Important new @msfaccess.org report highlights how even EU countries lack appropriate access to #tuberculosis medicines💊. "Bridging the gap: Securing access to essential #TB medicines in the EU and EEA" msfaccess.org/bridging-gap... (other high-income countries like Canada face similar challenges)

People with #TB in the EU/EEA region continue to face delayed or outdated access to treatment due to the unavailability, high price and fragmented supply of TB medicines. Read more about existing barriers and urgent recommendations for improving access to TB medications in the region.

“With more than half of unvaccinated children living in humanitarian settings around the world, now is the time to bolster access to vaccines”, urged Daniela Garone, MSF International Medical Coordinator, re: @gavi.org replenishment. msfaccess.org/Following-Ga...

Read this ground report by @stephanienolen.bsky.social concerning really grim situation of R&D of new medicines, tests and vaccines for many diseases in South Africa, post US funding cuts. South Africa is the beacon as said by Dr. Harold Varmus, a Professor who won Nobel prize in medicine.

Insulin pens must be affordable and available for all people with #diabetes who need them. Why? For many people with diabetes, using pens to administer insulin is easier, more accurate, and preferred over more difficult-to-use vials and syringes.